Bacteriocins: exploring alternatives to antibiotics in mastitis treatment
AUTOR(ES)
Pieterse, Reneé, Todorov, Svetoslav D.
FONTE
Brazilian Journal of Microbiology
DATA DE PUBLICAÇÃO
2010-10
RESUMO
Mastitis is considered to be the most costly disease affecting the dairy industry. Management strategies involve the extensive use of antibiotics to treat and prevent this disease. Prophylactic dosages of antibiotics used in mastitis control programmes could select for strains with resistance to antibiotics. In addition, a strong drive towards reducing antibiotic residues in animal food products has lead to research in finding alternative antimicrobial agents. In this review we have focus on the pathogenesis of the mastitis in dairy cows, existing antibiotic treatments and possible alternative for application of bacteriocins from lactic acid bacteria in the treatment and prevention of this disease.
Documentos Relacionados
- Bacteriocins: molecules of fundamental impact on the microbial ecology and potential food biopreservatives
- Structure-Function Analysis of Immunity Proteins of Pediocin-Like Bacteriocins: C-Terminal Parts of Immunity Proteins Are Involved in Specific Recognition of Cognate Bacteriocins
- Antibiotics for mastitis in breastfeeding women
- New biologically active hybrid bacteriocins constructed by combining regions from various pediocin-like bacteriocins: the C-terminal region is important for determining specificity.
- A failed RCT to determine if antibiotics prevent mastitis: Cracked nipples colonized with Staphylococcus aureus: A randomized treatment trial [ISRCTN65289389]
